This page is here to help waitlist patients understand how the pathway works, which diagnostic route may suit them, what to prepare, and what happens next.
We begin by collecting structured questionnaires, symptom history, and relevant medical background before the diagnostic consultation. This helps us build a clearer picture early rather than asking you to reconstruct everything later.
EDS-informed physiotherapy assessment helps us understand hypermobility, tissue features, autonomic signs, and functional impact. Pathology is also organised early so the diagnosing clinician is working from a more complete picture and so relevant differential diagnoses can be considered before the final diagnostic consultation.
Genetic testing is not required for hypermobile Ehlers-Danlos Syndrome. It is used selectively when features suggest a rarer or higher-risk connective tissue disorder, such as vascular or classical EDS.
Note: You are likely to have already completed steps 1-3 (where indicated)
Once the assessment work has been completed, diagnosis can proceed through either a GP-led or rheumatologist-led consultation, depending on clinical fit and patient preference.
After the diagnostic consultation, the outcome is formalised through structured documents and you return to your ongoing care team with the assessment findings held in one place.
Both routes sit within one structured diagnostic pathway. Both use the same diagnostic criteria and thresholds. The difference is which clinician is best placed to complete the final diagnostic consultation in your case.
.svg)
For many patients, GP-led diagnosis is a legitimate and appropriate option.
Hypermobile Ehlers-Danlos Syndrome is a clinical diagnosis. It does not require a geneticist. GP-led diagnosis is recognised by leading authorities using the 2017 international criteria, and at biio. it sits within a supervised specialist pathway.
This matters because it allows diagnosis to happen in a way that is more scalable, more cost-sensitive, and often faster, while keeping strong clinical oversight in place.
Rheumatology remains an important part of the pathway. It is available for all presentations and may be particularly useful where there is greater complexity, unresolved diagnostic uncertainty, inflammatory differentiation, or a need for specialist documentation.
For some patients seeking documentation for insurance or disability-related purposes, including some NDIS contexts, a rheumatologist-led diagnosis may be preferable. That does not mean GP-led diagnosis is invalid. It means specialist documentation may carry more weight in some settings.
This is the fee structure for the pathway.
New clinicians entering the biio. EDS assessment pathway will usually begin with a longer appointment format. As they become established in the pathway, they move to the shorter format. Because additional clinicians may continue to join the pathway, both formats may exist at the same time.
What matters most for most patients is the out-of-pocket cost.
.svg)
If you would prefer to wait for a shorter-format lower-cost appointment where available, you can indicate your preference.
Yes. A rheumatology consultation requires a valid referral.
No. A GP-led diagnostic consultation does not require a referral.
Your regular GP can provide this. Alternatively biio.’s NP’s are also available to write internal referrals for our rheumatologists.
You can still indicate your preference for rheumatology. If you are offered a rheumatology appointment, you will need to make sure your referral is ready.
Pathology is completed before the diagnostic consultation so the diagnosing clinician is working from a more complete picture and so relevant differential diagnoses can be considered early.
Download the pathology guide (PDF)
If your regular GP or NP orders the pathology for you, please ask them to request that our practice receives a copy of the pathology report.
You may also request a copy of the pathology report and upload it directly to the patient portal.
Please ensure results are provided at least one week before your diagnostic consultation.
Biio.’s NPs are available to handle all your pathology needs too.
biio. will contact you directly as booking windows open.
We will work in order as far as practical, with those who have been waiting the longest given priority wherever possible. It will not be a perfectly chronological queue.
In the early stages, some patients may be booked first because they already have the clearest and most complete existing assessment material. This helps new clinicians begin safely and consistently within the pathway.
In the early phase, face-to-face assessments often provide the strongest existing base for diagnosis. That makes them a practical starting point while newer clinicians become established in the pathway.
Patients assessed via telehealth will continue to move through the pathway as capacity broadens.
Yes. The pathway is designed to grow as additional clinicians become established within it.
The aim of the pathway is not only to reach a diagnosis, but to produce documentation that is clear, usable, and less reliant on repeated re-explanation.
You will receive a formal diagnostic report that clearly states the diagnosis or diagnostic conclusion and whether the criteria were met. The report brings together the key findings from the pathway, including objective measurements, diagnostic reasoning, and the overall pattern seen across the assessment. This is designed to meet basic insurance and disability documentation standards and to support workplace or educational accommodations where relevant.
Where relevant, documentation may also include communication to your usual care team, safety documentation, and patient information resources to support the next stage of care. The point of this documentation is to reduce the need for you to repeatedly reconstruct and re-explain your case across different systems.
Diagnosis at biio. is delivered through an integrated pathway involving physiotherapy, nurse practitioner support, GP-led diagnosis, rheumatology, and genetics where indicated. For current clinician bios, please visit the team page.
Yes. GP-led diagnosis is recognised and valid when used appropriately within a structured pathway and with the correct diagnostic criteria.
Rheumatology may be preferable where there is greater complexity, unresolved uncertainty, inflammatory differentiation, or a need for specialist documentation.
Yes. If that option is available, you can indicate that preference through the preference flow.
You need a referral for rheumatology. You do not need a referral for GP-led diagnosis.
Pathology helps rule out relevant differential diagnoses and gives the diagnosing clinician a more complete picture before the final consultation.
Yes. The pathway is designed to grow over time.